Cite
HARVARD Citation
Xu, J. et al. (n.d.). 79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC). Journal for immunotherapy of cancer. p. A86. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, J. et al. (n.d.). 79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC). Journal for immunotherapy of cancer. p. A86. [Online].